Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any familial nephrotic syndrome in which the cause of the disease is a mutation in the NUP107 gene.
Features include very common findings: Focal segmental glomerulosclerosis; and rarely findings: Ventricular septal defect, Enlarged and weakened heart (dilated cardiomyopathy), IgA deposition in the glomerulus, and Abnormal facial shape. 25 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Kidneys and urinary system | 7 | Stage 5 chronic kidney disease, Nephrotic syndrome, IgA deposition in the glomerulus |
NUP107 encodes nucleoporin 107 (925 aa). Plays a role in the nuclear pore complex (NPC) assembly and/or maintenance. Required for the assembly of peripheral proteins into the NPC. May anchor NUP62 to the NPC. Involved in nephrogenesis Highest expression in Cells EBV-transformed lymphocytes (28.5 TPM) and Testis (21.7 TPM).
Nephrotic syndrome, type 11 is associated with mutations in the NUP107 gene on chromosome 12.
NUP107 is classified as a druggable target (Transporter category) with score 0.0.
Genetic testing for NUP107 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for nephrotic syndrome, type 11 has been reported in the published literature.
Phenotype severity distribution: 1 very common feature.
No clinical trials have been registered for nephrotic syndrome, type 11.
43 publications have been identified in PubMed for nephrotic syndrome, type 11. Research spans Case Report / Case Series (30%), Epidemiology / Natural History (23%), and Review / Meta-Analysis (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 13 | 30% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 3:02 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Head and neck | 4 | Cleft lip, High palate, Cleft palate |
Heart and blood vessels | 2 | Ventricular septal defect, Enlarged and weakened heart (dilated cardiomyopathy) |
Brain and nerves | 2 | Delayed speech and language development, Global developmental delay |
Muscles | 1 | Renal tubular atrophy |
10 |
23% |
Research summaries | 6 | 14% |
Clinical study results | 5 | 12% |
Laboratory research | 5 | 12% |
New treatment approaches | 2 | 5% |
Other research | 1 | 2% |
Testing and diagnosis research | 1 | 2% |
Li H (2026). [PMID: 40388905](https://pubmed.ncbi.nlm.nih.gov/40388905/). *Am J Nephrol*. [Epidemiology / Natural History]
Gopal M (2026). [PMID: 42005116](https://pubmed.ncbi.nlm.nih.gov/42005116/). *Cureus*. [Epidemiology / Natural History]
Li Y (2026). [PMID: 42027551](https://pubmed.ncbi.nlm.nih.gov/42027551/). *Kidney Int Rep*. [Clinical Trial Publication]
Maekawa S (2026). [PMID: 41999621](https://pubmed.ncbi.nlm.nih.gov/41999621/). *Nephron*. [Case Report / Case Series]
Bai Q (2026). [PMID: 42021204](https://pubmed.ncbi.nlm.nih.gov/42021204/). *BMC Nephrol*. [Clinical Trial Publication]
Koshida T (2026). [PMID: 42047308](https://pubmed.ncbi.nlm.nih.gov/42047308/). *Nephrology (Carlton)*. [Case Report / Case Series]
Bhaumik A (2026). [PMID: 42078290](https://pubmed.ncbi.nlm.nih.gov/42078290/). *Cureus*. [Epidemiology / Natural History]
Ma Y (2026). [PMID: 42063792](https://pubmed.ncbi.nlm.nih.gov/42063792/). *Front Med (Lausanne)*. [Case Report / Case Series]
Dong R (2026). [PMID: 42116397](https://pubmed.ncbi.nlm.nih.gov/42116397/). *Medicine (Baltimore)*. [Epidemiology / Natural History]
Wang L (2026). [PMID: 41509998](https://pubmed.ncbi.nlm.nih.gov/41509998/). *Kidney Med*. [Clinical Trial Publication]